How does Carevive ensure data security?

In this video, Stan Norton, the Chief Technology Officer at Carevive, sheds light on the robust privacy measures implemented to protect patient data. At Carevive, patient privacy is of utmost importance, and the team is dedicated to upholding the highest standards.

To ensure compliance with federal regulations, the company conducts an annual HIPAA risk assessment. This comprehensive evaluation helps identify any potential gaps in their processes, enabling them to proactively address and mitigate risks.

Norton emphasizes the use of physical mechanisms, in accordance with HIPAA security rules, to securely store data in a high-trust, SOC 2 Type 2 certified cloud environment. Additionally, Carevive remains vigilant against cyberattacks, employing proper endpoint management to safeguard sensitive information.

With a long-standing commitment to data security and privacy, Carevive assures patients and partners that their data is handled with the utmost care and protection. The team welcomes any further discussions on their privacy measures and is always ready to provide more insights into their robust data protection practices.

Recent Episodes

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…